Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Aug;25(4):334-343.
doi: 10.1177/1073858418793077. Epub 2018 Aug 20.

Oligodendrocyte Bioenergetics in Health and Disease

Affiliations
Review

Oligodendrocyte Bioenergetics in Health and Disease

Lauren Rosko et al. Neuroscientist. 2019 Aug.

Abstract

The human brain weighs approximately 2% of the body; however, it consumes about 20% of a person's total energy intake. Cellular bioenergetics in the central nervous system involves a delicate balance between biochemical processes engaged in energy conversion and those responsible for respiration. Neurons have high energy demands, which rely on metabolic coupling with glia, such as with oligodendrocytes and astrocytes. It has been well established that astrocytes recycle and transport glutamine to neurons to make the essential neurotransmitters, glutamate and GABA, as well as shuttle lactate to support energy synthesis in neurons. However, the metabolic role of oligodendrocytes in the central nervous system is less clear. In this review, we discuss the energetic demands of oligodendrocytes in their survival and maturation, the impact of altered oligodendrocyte energetics on disease pathology, and the role of energetic metabolites, taurine, creatine, N-acetylaspartate, and biotin, in regulating oligodendrocyte function.

Keywords: bioenergetics; multiple sclerosis; neurodegeneration; oligodendrocytes; remyelination.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Mechanisms of energy metabolism in the myelinating oligodendrocyte (yellow). Lactate is taken up through the monocarboxylate transporter 1 (MCT1) from contact with astrocytes (red). Lactate can then be shuttled to and taken up by axons (pink) through the MCT2 on neurons. Conversely, lactate can be converted to pyruvate and transported to the mitochondria for the tricarboxylic acid (TCA) cycle or converted to ATP in the cytosol by glycolysis. Glucose can also be transported into oligodendrocytes by glucose transporters and converted to pyruvate. Small metabolites, creatine and taurine, contribute to oligodendrocyte stability. Creatine (Cr) is converted to phosphocreatine (PCr) and serves as a phosphate pool in the cytosol to aid in ATP production and promote cell survival. PCr may serve as energy source for myelin synthesis. Taurine increases serine pools to stimulate myelin synthesis within the cell.
Figure 2.
Figure 2.
Metabolite exchange between oligodendrocyte (yellow) and axons (pink) in health and disease. In the healthy CNS, oligodendrocyte-axon coupling allows for bidirectional exchange of metabolites. In multiple sclerosis (MS), damage to myelin, axonal dystrophy, and dying back of oligodendrocytes leads to disrupted oligodendrocyte-axon coupling and impaired metabolite exchange. Figure created in BioRender.
Figure 3.
Figure 3.
Uptake of taurine in oligodendrocyte precursor cells (OPCs) promotes differentiation and myelin synthesis. Taurine increases serine pools which enhances oligodendrocyte differentiation and promotes glycosphingolipid synthesis. Glycosphingolipid biosynthesis is essential for myelin synthesis. Figure created in BioRender.
Figure 4.
Figure 4.
Creatine increases mitochondrial density in oligodendrocytes. A significant increase in mitochondria density was calculated in myelin basic protein (MBP)–positive oligodendrocytes after treatment with 100 µM creatine (CR) for 24 hours. Oligodendrocytes treated with PBS or treated with creatine plus guanidinopropionic acid (GPA), a competitive antagonist to the creatine transporter, showed similar mitochondrial density. Modified from Chamberlain and others (2017).
Figure 5.
Figure 5.
Neuronal-derived N-acetylacetate (NAA) promotes myelin synthesis and energy production in oligodendrocytes (yellow). NAA is synthesized in neurons (pink) from acetyl-CoA and aspartate by aspartate N-acetyltransferase (Asp-NAT). In oligodendrocytes, NAA is metabolized by aspartoacylase (ASPA) into acetate and aspartate, which are used for myelin synthesis and energy production via the malate-aspartate shuttle (Mal-Asp shuttle), respectively. Figure created in BioRender.
Figure 6.
Figure 6.
Biotin promotes myelin synthesis and energy production by acting as a coenzyme in oligodendrocytes (yellow) and neurons (pink). In oligodendrocytes, biotin (green) binds with acetyl-CoA carboxylase (ACC1 and ACC2) (blue) and increases the availability of fatty acids, allowing increased myelin synthesis. In neurons, biotin binds tricarboxylic acid (TCA) cycle enzymes (pyruvate carboxylase, 3-methylcrotonyl-CoA carboxylase, propionyl-CoA carboxylase) (purple) and increases production of TCA cycle intermediates, increasing ATP production and reducing neuronal hypoxia. Figure created in BioRender.

Similar articles

Cited by

References

    1. Adhihetty PJ, Beal MF. (2008). Creatine and its potential therapeutic value for targeting cellular energy impairment in neurodegenerative diseases. Neuromolecular Med 10:275–90. - PMC - PubMed
    1. Adiele RC, Adiele CA. (2017). Metabolic defects in multiple sclerosis. Mitochondrion. Epub Dec 13. doi:10.1016/j.mito.2017.12.005. - DOI - PubMed
    1. Amaral AI, Hadera MG, Kotter M, Sonnewald U. (2017). Oligodendrocytes do not export NAA-derived aspartate in vitro. Neurochem Res 42:827–37. - PMC - PubMed
    1. Béard E, Braissant O. (2010). Synthesis and transport of creatine in the CNS: importance for cerebral functions. J Neurochem 115:297–313. - PubMed
    1. Beyer BA, Fang M, Sadrian B, Montenegro-Burke JR, Plaisted WC, Kok BPC, and others. (2018). Metabolomics-based discovery of a metabolite that enhances oligodendrocyte maturation. Nat Chem Biol 14:22–8. - PMC - PubMed

Publication types

LinkOut - more resources